Boston Scientific Corp (BSX)
90.00
-1.50
(-1.64%)
USD |
NYSE |
Nov 22, 16:00
89.98
-0.02
(-0.02%)
Pre-Market: 20:00
Boston Scientific Cash from Investing (Quarterly): -1.427B for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -1.427B |
| June 30, 2024 | -271.00M |
| March 31, 2024 | -285.00M |
| December 31, 2023 | -1.053B |
| September 30, 2023 | -197.00M |
| June 30, 2023 | -840.00M |
| March 31, 2023 | -484.00M |
| December 31, 2022 | -183.00M |
| September 30, 2022 | -225.00M |
| June 30, 2022 | -29.00M |
| March 31, 2022 | -1.574B |
| December 31, 2021 | -461.00M |
| September 30, 2021 | -1.207B |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 71.00M |
| December 31, 2020 | -147.00M |
| September 30, 2020 | -129.00M |
| June 30, 2020 | -59.00M |
| March 31, 2020 | -76.00M |
| December 31, 2019 | -49.00M |
| September 30, 2019 | -3.962B |
| June 30, 2019 | -620.00M |
| March 31, 2019 | -410.00M |
| December 31, 2018 | -595.00M |
| September 30, 2018 | -662.00M |
| Date | Value |
|---|---|
| June 30, 2018 | -491.00M |
| March 31, 2018 | -173.00M |
| December 31, 2017 | -289.00M |
| September 30, 2017 | -102.00M |
| June 30, 2017 | -479.00M |
| March 31, 2017 | -140.00M |
| December 31, 2016 | -532.00M |
| September 30, 2016 | -205.00M |
| June 30, 2016 | -102.00M |
| March 31, 2016 | -48.00M |
| December 31, 2015 | -170.00M |
| September 30, 2015 | -1.719B |
| June 30, 2015 | -246.00M |
| March 31, 2015 | -51.00M |
| December 31, 2014 | -83.00M |
| September 30, 2014 | -473.00M |
| June 30, 2014 | -124.00M |
| March 31, 2014 | -65.00M |
| December 31, 2013 | -363.00M |
| September 30, 2013 | -73.00M |
| June 30, 2013 | -28.00M |
| March 31, 2013 | -11.00M |
| December 31, 2012 | -273.00M |
| September 30, 2012 | -53.00M |
| June 30, 2012 | -187.00M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-1.574B
Minimum
Mar 2022
71.00M
Maximum
Mar 2021
-431.25M
Average
-211.00M
Median
Cash from Investing (Quarterly) Benchmarks
| Baxter International Inc | -164.00M |
| Haemonetics Corp | -23.37M |
| ResMed Inc | 2.146M |
| Globus Medical Inc | -14.97M |
| Abbott Laboratories | -594.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.002B |
| Cash from Financing (Quarterly) | 7.00M |
| Free Cash Flow | 1.892B |
| Free Cash Flow Per Share (Quarterly) | 0.4693 |
| Free Cash Flow to Equity (Quarterly) | 384.00M |
| Free Cash Flow to Firm (Quarterly) | 753.38M |
| Free Cash Flow Yield | 1.42% |